BioMarin Pharmaceuticals
BMRN
BMRN
574 hedge funds and large institutions have $10.1B invested in BioMarin Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 239 increasing their positions, 184 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
574
Holders Change
-5
Holders Change %
-0.86%
% of All Funds
7.7%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.09%
New
85
Increased
239
Reduced
184
Closed
82
Calls
$81.1M
Puts
$73M
Net Calls
+$8.09M
Net Calls Change
-$1.92M
Top Buyers
1 |
AQR Capital Management
Greenwich,
Connecticut
|
$306M |
2 |
Millennium Management
New York
|
$156M |
3 |
Viking Global Investors
Stamford,
Connecticut
|
$676M |
4 |
Morgan Stanley
New York
|
$134M |
5 |
Renaissance Technologies
New York
|
$99.3M |